Procalcitonin and mid-regional pro-adrenomedullin as promising markers for sepsis diagnosis and prog

• 作 者: Silvia Angeletti Rossella Ottaviani Arcangela Michela Lanotte Lucia Pedicino Marina De Cesaris Alessandra Lo Presti Eleonora Cella Marta Fogolari Massimo Ciccozzi Giordano Dicuonzo
• 机 构: Unit of Clinical Pathology and Microbiology, Campus Bio-Medico University of Rome,Department of Infe
• 出 处: Asian Pacific Journal of Tropical Biomedicine
• 发表日期: 2016年11期

To the Editor,We read with great interest the recent review by Limongi et al.on sepsis biomarkers[1].Recently,the combined use of two biomarkers,procalcitonin(PCT)and mid-regional proadrenomedullin(MR-pro ADM)has been reported in sepsis diagnosis and prognosis.PCT is a polypeptide produced as a precursor of calcitonin by thyroid C cells normally not

To the Editor, We read with great interest the recent review by Limongi et al. On sepsis biomarkers [1]. Century, the combined use of two biomarkers, procalcitonin (PCT) and mid- regional proadrenomedullin (MR-pro ADM) has been reported in sepsis diagnosis and prognosis. PCT is a polypeptide produced as a precursor of calcitonin by thyroid C cells normally not